Palmitate Induces Mitochondrial Energy Metabolism Disorder and Cellular Damage via the PPAR Signaling Pathway in Diabetic Cardiomyopathy

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Bell DSH, Goncalves E. Heart failure in the patient with diabetes: epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications. Diabetes Obes Metab. 2019;21(6):1277–1290. doi:10.1111/dom.13652
   Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–28. doi:10.1007/s00125-017-4390-4
   PubMed Web of Science ®Google Scholar
• Murtaza G, Virk HUH, Khalid M, et al. Diabetic cardiomyopathy - A comprehensive updated review. Prog Cardiovasc Dis. 2019;62(4):315–326. doi:10.1016/j.pcad.2019.03.003
   PubMed Web of Science ®Google Scholar
• Filardi T, Ghinassi B, Di Baldassarre A, et al. Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte. Int J Mol Sci. 2019;20(13):3299. doi:10.3390/ijms20133299
   PubMed Web of Science ®Google Scholar
• Gandoy-Fieiras N, Gonzalez-Juanatey JR, Eiras S. Myocardium metabolism in physiological and pathophysiological states: implications of epicardial adipose tissue and potential therapeutic targets. Int J Mol Sci. 2020;21(7):2641. doi:10.3390/ijms21072641
   Web of Science ®Google Scholar
• Szablewski L. Glucose transporters in healthy heart and in cardiac disease. Int J Cardiol. 2017;230:70–75. doi:10.1016/j.ijcard.2016.12.083
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15(6):805–812. doi:10.1016/j.cmet.2012.04.006
   PubMed Web of Science ®Google Scholar
• Cerf ME. Cardiac glucolipotoxicity and cardiovascular outcomes. Medicina. 2018;54(5):70. doi:10.3390/medicina54050070
   Web of Science ®Google Scholar
• Brindley DN, Kok BP, Kienesberger PC, Lehner R, Dyck JR. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab. 2010;298(5):E897–E908. doi:10.1152/ajpendo.00509.2009
   PubMed Web of Science ®Google Scholar
• Federico M, De la Fuente S, Palomeque J, Sheu SS. The role of mitochondria in metabolic disease: a special emphasis on heart dysfunction. J Physiol. 2021;599(14):3477–3493. doi:10.1113/JP279376
   Web of Science ®Google Scholar
• Wang L, Cai Y, Jian L, Cheung CW, Zhang L, Xia Z. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovasc Diabetol. 2021;20(1):2. doi:10.1186/s12933-020-01188-0
   PubMed Web of Science ®Google Scholar
• Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809–823. doi:10.1038/s41569-021-00569-6
   PubMed Web of Science ®Google Scholar
• Rius-Pérez S, Torres-Cuevas I, Millán I, Ál O, Pérez S. PGC-1α, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev. 2020;2020:1452696. doi:10.1155/2020/1452696
   PubMed Web of Science ®Google Scholar
• Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications. Eur J Med Chem. 2019;166:502–513. doi:10.1016/j.ejmech.2019.01.067
   PubMed Web of Science ®Google Scholar
• Li SY, Susztak K. The role of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) in kidney disease. Semin Nephrol. 2018;38(2):121–126. doi:10.1016/j.semnephrol.2018.01.003
   PubMed Web of Science ®Google Scholar
• Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1066–1077. doi:10.1016/j.bbadis.2016.11.010
   PubMed Web of Science ®Google Scholar
• Cadenas S. Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg. 2018;1859(9):940–950. doi:10.1016/j.bbabio.2018.05.019
   PubMed Web of Science ®Google Scholar
• Kutsche HS, Schreckenberg R, Weber M, et al. Alterations in glucose metabolism during the transition to heart failure: the contribution of UCP-2. Cells. 2020;9(3):552. doi:10.3390/cells9030552
   Web of Science ®Google Scholar
• Gerber LK, Aronow BJ, Matlib MA. Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat hearts. Am J Physiol Cell Physiol. 2006;291(6):C1198–C1207. doi:10.1152/ajpcell.00246.2006
   Web of Science ®Google Scholar
• Wu KM, Hsu YM, Ying MC, et al. High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression. Nutr Metab. 2019;16:36. doi:10.1186/s12986-019-0356-5
   Google Scholar
• Wen SY, Velmurugan BK, Day CH, et al. High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte. J Cell Physiol. 2017;232(11):3020–3029. doi:10.1002/jcp.26007
   PubMed Web of Science ®Google Scholar
• Gui T, Li Y, Zhang S, et al. Docosahexaenoic acid protects against palmitate-induced mitochondrial dysfunction in diabetic cardiomyopathy. Biomed Pharmacother. 2020;128:110306. doi:10.1016/j.biopha.2020.110306
   Web of Science ®Google Scholar
• Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res. 2020;126(11):1501–1525. doi:10.1161/CIRCRESAHA.120.315913
   PubMed Web of Science ®Google Scholar
• Dirkx E, Schwenk RW, Glatz JF, Luiken JJ, van Eys GJ. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot Essent Fatty Acids. 2011;85(5):219–225. doi:10.1016/j.plefa.2011.04.018
   Web of Science ®Google Scholar
• Chong CR, Clarke K, Levelt E. Metabolic remodeling in diabetic cardiomyopathy. Cardiovasc Res. 2017;113(4):422–430. doi:10.1093/cvr/cvx018
   PubMed Web of Science ®Google Scholar
• Lamichane S, Dahal Lamichane B, Kwon SM. Pivotal roles of peroxisome proliferator-activated receptors (PPARs) and their signal cascade for cellular and whole-body energy homeostasis. Int J Mol Sci. 2018;19(4):949. doi:10.3390/ijms19040949
   PubMed Web of Science ®Google Scholar
• Standage SW, Waworuntu RL, Delaney MA, et al. Nonhematopoietic peroxisome proliferator-activated receptor-α protects against cardiac injury and enhances survival in experimental polymicrobial sepsis. Crit Care Med. 2016;44(8):e594–e603. doi:10.1097/CCM.0000000000001585
   PubMed Web of Science ®Google Scholar
• Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002;109(1):121–130. doi:10.1172/JCI0214080
   PubMed Web of Science ®Google Scholar
• Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638. doi:10.1161/CIRCRESAHA.117.311586
   PubMed Web of Science ®Google Scholar
• Ding G, Fu M, Qin Q, et al. Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res. 2007;76(2):269–279. doi:10.1016/j.cardiores.2007.06.027
   Web of Science ®Google Scholar
• Wipperman MF, Montrose DC, Gotto AM, Hajjar DP. Mammalian target of rapamycin: a metabolic rheostat for regulating adipose tissue function and cardiovascular health. Am J Pathol. 2019;189(3):492–501. doi:10.1016/j.ajpath.2018.11.013
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Forte M, Frati G, Sadoshima J. New insights into the role of mTOR signaling in the cardiovascular system. Circ Res. 2018;122(3):489–505. doi:10.1161/CIRCRESAHA.117.311147
   PubMed Web of Science ®Google Scholar
• Zhu Y, Soto J, Anderson B, et al. Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α. Am J Physiol Heart Circ Physiol. 2013;305(1):H41–H51. doi:10.1152/ajpheart.00877.2012
   Web of Science ®Google Scholar
• Shende P, Plaisance I, Morandi C, et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation. 2011;123(10):1073–1082. doi:10.1161/CIRCULATIONAHA.110.977066
   Web of Science ®Google Scholar
• Lu Z, Xu X, Hu X, et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal. 2010;13(7):1011–1022. doi:10.1089/ars.2009.2940
   PubMed Web of Science ®Google Scholar
• Mitra R, Nogee DP, Zechner JF, et al. The transcriptional coactivators, PGC-1α and β, cooperate to maintain cardiac mitochondrial function during the early stages of insulin resistance. J Mol Cell Cardiol. 2012;52(3):701–710. doi:10.1016/j.yjmcc.2011.10.010
   Web of Science ®Google Scholar
• Duncan JG, Fong JL, Medeiros DM, et al. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation. 2007;115(7):909–917. doi:10.1161/CIRCULATIONAHA.106.662296
   PubMed Web of Science ®Google Scholar
• Lee TW, Bai KJ, Lee TI, Chao TF, Kao YH, Chen YJ. PPARs modulate cardiac metabolism and mitochondrial function in diabetes. J Biomed Sci. 2017;24(1):5. doi:10.1186/s12929-016-0309-5
   Web of Science ®Google Scholar
• Monteiro BS, Freire-Brito L, Carrageta DF, Oliveira PF, Alves MG. Mitochondrial uncoupling proteins (UCPs) as key modulators of ROS homeostasis: a crosstalk between diabesity and male infertility? Antioxidants. 2021;10(11):1746. doi:10.3390/antiox10111746
   Web of Science ®Google Scholar
• Schilling JD. The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise. Antioxid Redox Signal. 2015;22(17):1515–1526. doi:10.1089/ars.2015.6294
   Web of Science ®Google Scholar